| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027981 |
| Receipt No. | R000032043 |
| Scientific Title | A prospective observational study to examine relationships between blood pressure variability and adherence to continuous positive airway pressure therapy in patients with hypertension and obstructive sleep apnea |
| Date of disclosure of the study information | 2017/06/28 |
| Last modified on | 2020/08/25 (Ver. 4) |
| Basic information | ||
| Public title | A prospective observational study to examine relationships between blood pressure variability and adherence to continuous positive airway pressure therapy in patients with hypertension and obstructive sleep apnea | |
| Acronym | B-PAP Study | |
| Scientific Title | A prospective observational study to examine relationships between blood pressure variability and adherence to continuous positive airway pressure therapy in patients with hypertension and obstructive sleep apnea | |
| Scientific Title:Acronym | B-PAP Study | |
| Region |
|
|
| Condition | ||
| Condition | Hypertensive patients with obstructive apnea (OSA) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the influence of adherence to CPAP on home blood pressure in hypertensive patients with OSA, and it's secondary effects on organ damages. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | A relationship between daily early morning blood pressure (systolic) and usage hours of CPAP in each night. |
| Key secondary outcomes | 1.A relationship between daily early morning blood pressure (diastolic) and usage hours of CPAP in each night
2.A relationship between an average / variation of clinic blood pressure (systolic and diastolic) and an average / variation of usage hours of CPAP in this time period. 3.A relationship between the change of various indicators that can evaluate organ damages and an average usage hours of CPAP during the time period 4.Factors associated with the usage hours of CPAP |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who satisfy all of the following criteria
1.Outpatients diagnosed with hypertension. 2.Patients who undergo overnight sleep polygraph test at the medical institution, with AHI > 20, and have obstructive apneas accounting for more than half of total number of apneas. 3.Patients who already begun or are scheduled to begin treatment with a designated CPAP therapy device (sleepmate 9 or 10). 4.Patients who are already using NemLink or are scheduled to use it. 5.Patients aged 20 years or more at consent acquisition. 6.Patients who have got a written consent from himself/herself. 7.Patients who gave a consent to participate in the PREDICT study. (UMINID:UMIN000019871) |
|||
| Key exclusion criteria | 1.Patients within 3 months of the onset of acute coronary syndrome (ACS).
2.Patients who can not walk independently. 3.Patients with severe chronic respiratory failure or chronic obstructive pulmonary disease. 4.Patients with severe chronic heart failure or chronic heart disease. 5.Patients diagnosed with arrhythmia such as atrial fibrillation. 6.Patients with central nervous system disorders caused by a stroke, or injuries. 7.Dialysis patient. 8.Patients whose QOL is restricted due to malignant tumor or other diseases. 9.Patients diagnosed with dementia. 10.Patients without the ability of giving a consent or the patients who are doubted for having the ability. 11.Other patients who are judged as unsuitable for this study by the Attending physician. |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Jichi Medical University School of Medicine | ||||||
| Division name | Division of Cardiovascular, Medicine, Department of Medicine | ||||||
| Zip code | |||||||
| Address | 3311-1 Yakushiji, Shimotsuke-shi,Tochigi, Japan 329-0498 | ||||||
| TEL | 0285-58-7344 | ||||||
| kkario@jichi.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Jichi Medical University School of Medicine | ||||||
| Division name | Division of Cardiovascular, Medicine, Department of Medicine | ||||||
| Zip code | |||||||
| Address | 3311-1 Yakushiji, Shimotsuke-shi,Tochigi, Japan 329-0498 | ||||||
| TEL | 0285-58-7344 | ||||||
| Homepage URL | |||||||
| hoshide@jichi.ac.jp | |||||||
| Sponsor | |
| Institute | Jichi Medical University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Teijin Pharma Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 自治医科大学(栃木県) 鷲谷病院(栃木県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This is a prospective cohort study.
Recruitment of Target : Those who agree with the selection criteria for patients who visited facilities implemented from June to December 2017. Tracking period : One year every month. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032043 |